In brief: NPG #14 requires hospitals to maintain and communicate accurate patient medication information (Joint Commission, 2025). The core practice is medication reconciliation: creating the most accurate list of all medications a patient takes and comparing it against the prescriber’s orders at every transition of care (Penm et al., 2019). Unintended discrepancies at admission are common (Cornish et al., 2005), but whether reconciliation reduces readmissions or harm remains contested (Kwan et al., 2013; Redmond et al., 2018).
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce University, Faculty of Business, Department of Health Management
Abstract. Part 5 covers the largest body of evidence in the series: 2,005 hospital records on medication reconciliation in a 4,936-record Web of Science corpus. The chapter traces reconciliation from early ICU discharge checklists to multicentre quality improvement programmes, defines its key terms (best possible medication history, intentional and unintentional discrepancies), and compares pharmacist-led, technician-supported and electronic models. Evidence consistently shows that discrepancies are frequent and reducible; evidence on clinical outcomes is mixed and of low certainty, which is the central debate of the field.
Series: Effectively Managing Medications (Joint Commission NPG #14)
- Series guide: Effectively Managing Medications (NPG #14)
- Part 1. Pharmacist Order Review When the Pharmacy Is Closed
- Part 2. Automated Dispensing Cabinets and Overrides
- Part 3. Medication Selection, Procurement and Shortages
- Part 4. Perioperative and Procedural Medication Labeling
- Part 5. Medication Reconciliation (you are here)
- Part 6. Anticoagulant Safety
- Part 7. Antimicrobial Stewardship in Hospitals
Learning objectives
After completing this chapter, the reader will be able to:
- Define medication reconciliation, best possible medication history and unintentional medication discrepancy.
- Explain how the NPG #14 requirement on accurate medication information is operationalised in hospitals.
- Describe the frequency and risk factors of discrepancies at admission and discharge.
- Compare pharmacist-led, team-based and electronic reconciliation models.
- Critically appraise the evidence on clinical outcomes such as readmissions.
- Plan a reconciliation process for a high-risk patient group.
Key concepts: medication reconciliation, best possible medication history (BPMH), unintentional medication discrepancy, transition of care, medication review, potential adverse drug event, polypharmacy
Contents
- 1. Introduction
- 2. History and development
- 3. Definitions and conceptual schema
- 4. Distinguishing neighbouring concepts
- 5. Types and classifications
- 6. Theoretical frameworks and models
- 7. Themes and bibliometric profile
- 8. The situation in Türkiye
- 9. Debates and contradictions in the literature
- 10. Measurement problems
- 11. Research gaps and agenda
- 12. Relevance today and practical implications
- Summary box, discussion questions, further reading, glossary and references
Method box: how this chapter was produced
| Component | Application |
|---|---|
| Source document | Joint Commission (2025), National Performance Goal #14 “Effectively Managing Medications” (formerly part of the National Patient Safety Goals). (Joint Commission, 2025) |
| Database and indexes | Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI) |
| Search strategy (series) | Seven component blocks derived from the NPG #14 requirements, a core medication safety block and a hospital context block; combined set #24 = ((#1 AND component blocks 1-4) OR medication reconciliation OR anticoagulant block) AND hospital block, OR the title-based stewardship block; filtered to articles and reviews, English, 2000-2026. |
| Component query (this chapter) | TS=("medication reconciliation" OR "medicines reconciliation" OR "drug reconciliation" OR "best possible medication history" OR "medication discrepanc*" OR "medication history taking" OR "medication information transfer") |
| Core block | TS=("medication safety" OR "medication error*" OR "medication mistake*" OR "drug error*" OR "prescribing error*" OR "prescription error*" OR "dispensing error*" OR "administration error*" OR "transcription error*" OR "adverse drug event*" OR "preventable adverse drug*" OR "medication-related harm" OR "medication incident*" OR "medication management" OR "medication use process" OR "safe medication" OR "high-alert medication*" OR "wrong drug" OR "wrong dose" OR "wrong route") |
| Search date and span | 16 November 2026; publication years 2000-2026 (2027 early-access records retained) |
| Inclusion and exclusion | Included: hospital-context records matching this component. Excluded: retracted publications and records whose only labeling match was “open-label”. |
| Screening counts | Series corpus 4,936; tagged for this component 2,005; excluded 0; eligible 2,005; core evidence set (component term in title or author keywords) 956; “patient safety” framed 488. |
| Evidence extraction | Definitions, milestones, models, measures, debates and gaps were extracted from the abstracts of the most cited and most recent records in the core set. |
| Limitations | Single database; English only; component tagging is rule based and reproduces the WoS query on title, abstract and keywords (agreement within 5 records per component); evidence read at abstract level; full texts were not read. |
1. Introduction
When an 82-year-old patient is admitted through the emergency department, the admitting team must know exactly what she was taking at home: names, doses, timing, over-the-counter products. If the list is wrong, an omitted anticoagulant or a duplicated antihypertensive will follow her through the stay and into the discharge letter. In a landmark study more than half of patients had at least one unintended discrepancy at admission, and some had the potential to cause harm (Cornish et al., 2005).
NPG #14 states the requirement in one line: the hospital maintains and communicates accurate patient medication information (Joint Commission, 2025). Behind that line lies a two-decade body of research on how to build an accurate list, compare it, resolve differences and hand it on.
2. History and development
Reconciliation emerged as a named practice in the early 2000s. In 2003 a structured discharge survey in an intensive care unit nearly eliminated medication errors in discharge orders (Pronovost et al., 2003). Studies in 2005 documented discrepancies at admission (Cornish et al., 2005) and after discharge to home (Coleman et al., 2005), and a 2007 review placed medication problems at the centre of safe transitions (Kripalani et al., 2007).
Around 2008-2010, research moved to classifying errors and risk factors (Gleason et al., 2010; Pippins et al., 2008), testing electronic tools in randomised designs (Schnipper et al., 2009) and stating consensus principles for patient-centred, implementable reconciliation (Greenwald et al., 2010). Systematic reviews from 2012 onward assessed effectiveness (Kwan et al., 2013; Mekonnen et al., 2016; Mueller et al., 2012). An international Delphi produced a broader consensus definition in 2019 (Penm et al., 2019), and multicentre quality improvement programmes followed (Schnipper et al., 2022). NPG #14 frames the practice as accurate medication information (Joint Commission, 2025).
3. Definitions and conceptual schema
Definitions moved from a narrow list comparison to a broader process across all transitions.
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Kwan et al. (2013) | 2013 | Internal medicine | Reconciliation identifies and resolves unintentional discrepancies between medication lists across transitions in care. | Discrepancy resolution |
| Penm et al. (2019) | 2019 | Pharmacy (Delphi) | Creating the most accurate list of all medications and comparing it with prescriber orders, including allergies and side-effect history, at all transition points. | Completeness and every transition |
| Climente-Martí et al. (2010) | 2010 | Hospital pharmacy | Medication discrepancies are unexplained variations among drug regimens at care transitions. | Unexplained variation |
| Greenwald et al. (2010) | 2010 | Hospital medicine | Reconciliation should be patient centred, clinically relevant and implementable; a common definition of the process is still needed. | Feasibility and patient focus |
| Joint Commission (2025) | 2025 | Accreditation | The hospital maintains and communicates accurate patient medication information. | Information continuity |
The shared core is an accurate, complete list compared at transitions. Definitions diverge on scope (only discrepancies or also appropriateness), on who is responsible, on which transitions count (admission, transfer, discharge) and on whether communication to the next provider is part of the process.
4. Distinguishing neighbouring concepts
Reconciliation is often bundled with medication review, a structured evaluation of a patient’s medication aimed at optimising use and outcomes (Bülow et al., 2023), and with discharge counselling and follow-up within transitional care programmes (Phatak et al., 2016). Reconciliation asks “is the list correct and consistent?”; medication review asks “is the regimen appropriate?”.
The distinction matters because trials often combine them; reconciliation alone probably does not reduce post-discharge utilisation but may do so when bundled with other transition interventions (Kwan et al., 2013).
5. Types and classifications
The corpus distinguishes reconciliation by transition point and by delivery model.
| Model | Description | Corpus evidence |
|---|---|---|
| Pharmacist-led | Pharmacists or pharmacy technicians take the history and reconcile | Effective on discrepancies and post-hospital utilisation in meta-analyses (Mekonnen et al., 2016; Mekonnen et al., 2016) |
| Electronic | Software and process redesign integrated with records | Fewer unintentional discrepancies with potential for harm (Schnipper et al., 2009) |
| Multicomponent QI | Toolkit and mentored implementation across hospitals | Substantial decrease in discrepancies over time (Schnipper et al., 2022) |
| Admission-only | Reconciliation at admission | No effect on 30-day returns in very old patients (Ceschi et al., 2021) |
| Combined with ward rounds | Reconciliation plus interprofessional rounds | Fewer drug-related problems at discharge (Studer et al., 2023) |
6. Theoretical frameworks and models
Two models structure the field. The transition-of-care model treats each handover as a point of information loss and builds safeguards around it (Kripalani et al., 2007). The error classification model separates history errors from reconciliation errors at ordering, and identifies risk factors such as advanced age and number of medications (Gleason et al., 2010; Pippins et al., 2008).
Implementation science supplies a third frame: mentored implementation of evidence-based toolkits across many hospitals (Schnipper et al., 2022), and consensus statements that place patient safety ahead of accreditation compliance (Greenwald et al., 2010).
7. Themes and bibliometric profile
The eligible subcorpus holds 2,005 records (247 of them reviews) with 46,236 citations in the WoS Core Collection. 133 records appeared in 2000-2010 and 1,530 in 2016-2026, so most of the evidence is recent (Figure 5). The leading journals are International Journal of Clinical Pharmacy (94), American Journal of Health-system Pharmacy (93), BMC Health Services Research (54), Research in Social & Administrative Pharmacy (54). By author address the most active countries are United States (888), Australia (162), Canada (140), England (125), Netherlands (83). The most frequent author keywords are: medication reconciliation, patient safety, medication errors, medication safety, transitions of care, pharmacists, clinical pharmacy, pharmacist, polypharmacy, medication discrepancies. 488 records (24%) explicitly frame their topic with the term “patient safety”.
The dominant themes are (1) frequency of discrepancies at admission and discharge (Breuker et al., 2021; Cornish et al., 2005; Wong et al., 2008); (2) pharmacist roles (Cornu et al., 2012; Mekonnen et al., 2016); (3) outcomes such as readmissions (Ceschi et al., 2021; Lehnbom et al., 2014); (4) older adults and polypharmacy (Bülow et al., 2023; Gleason et al., 2010).
8. The situation in Türkiye
Eleven records in the subcorpus have a Turkish address. A Turkish study of elderly patients at hospital admission found frequent medication-related problems and an 85.6% acceptance rate of clinical pharmacist recommendations made through reconciliation and medication review (Selcuk et al., 2015). A 2025 study reported better adherence and outcomes after pharmacist-led pharmaceutical care for stroke patients (Cengiz et al., 2025). Evidence on routine, hospital-wide reconciliation in Türkiye is not present in the corpus.
9. Debates and contradictions in the literature
Axis 1: process gains versus clinical outcomes. Reconciliation reliably reduces discrepancies (Mueller et al., 2012; Schnipper et al., 2022), and pharmacist-led programmes reduced post-hospital utilisation in a meta-analysis (Mekonnen et al., 2016). Yet other reviews conclude that there is limited evidence of clinical impact (Lehnbom et al., 2014), a Cochrane review rates the certainty of evidence as very low (Redmond et al., 2018), and a randomised trial found no effect on 30-day returns in very old patients (Ceschi et al., 2021).
Axis 2: accreditation compliance versus patient safety. Consensus authors warned that reconciliation should focus on patient safety rather than accreditation (Greenwald et al., 2010). The concern is that a checklist can be completed without producing an accurate list.
Axis 3: who should do it? Pharmacy staff produce the strongest effects (Mueller et al., 2012), but workforce limits raise questions about technicians and physicians, and the role of pharmacy technicians needs further study (Mekonnen et al., 2016).
10. Measurement problems
The primary measure is the number of unintentional discrepancies, judged against a best possible medication history; definitions vary, which makes rates difficult to compare (Climente-Martí et al., 2010; Greenwald et al., 2010). Potential harm is rated by expert panels, which introduces subjectivity.
Clinical outcomes such as readmissions are distal and influenced by many factors, so trials need large samples; the very low certainty of the evidence reflects this (Redmond et al., 2018). Medication review trials show similar problems, with little effect on mortality and uncertain effects on quality of life (Bülow et al., 2023).
11. Research gaps and agenda
The following questions are framed so that they can be answered by empirical studies; each notes the evidence gap it derives from.
- Which patients benefit most from pharmacist-led reconciliation? (Effects concentrate in high-risk groups; selection rules are untested.)
- Does reconciliation at all transitions reduce harm more than admission-only reconciliation? (Multiple transitions were less effective in meta-analysis.)
- What is the effect of reconciliation on clinically significant adverse drug events, not only discrepancies? (Certainty is very low.)
- Can pharmacy technicians deliver reconciliation with the same accuracy? (Identified as a need.)
- How well do electronic health records support an accurate shared medication list? (Software integration is a known barrier.)
- What is the frequency of discrepancies in Turkish hospitals at discharge? (Turkish evidence focuses on admission and selected groups.)
12. Relevance today and practical implications
A minimal NPG #14 process: (1) a best possible medication history from at least two sources within 24 hours of admission for high-risk patients (Breuker et al., 2021); (2) documented comparison with admission orders, with every change labelled intentional or unintentional; (3) reconciliation again at transfer and discharge; (4) an updated list given to the patient and the next provider (Joint Commission, 2025). Priority should go to older patients with many medications (Gleason et al., 2010), and the process should be audited for accuracy, not only completion (Greenwald et al., 2010).
Summary box
- Medication reconciliation creates an accurate medication list and compares it with orders at every transition.
- Unintended discrepancies at admission and discharge are common and sometimes harmful.
- Pharmacist-led and multicomponent programmes reduce discrepancies.
- Evidence on clinical outcomes such as readmissions is mixed and of low certainty.
- Reconciliation differs from medication review, which judges appropriateness.
- Turkish studies show high acceptance of pharmacist recommendations at admission.
Discussion questions
- Why is a best possible medication history built from more than one source?
- Distinguish an intentional from an unintentional discrepancy with an example.
- Why might reconciliation reduce discrepancies but not readmissions?
- What risks arise if reconciliation becomes a checkbox for accreditation?
- Application: design a reconciliation workflow for patients aged 75 and over with ten or more medications.
- Application: define three indicators to audit reconciliation quality.
Further reading
- Cornish et al. (2005): the classic admission discrepancy study.
- Kwan et al. (2013): a balanced systematic review of reconciliation as a safety strategy.
- Mekonnen et al. (2016): meta-analysis of pharmacist-led programmes.
- Redmond et al. (2018): the cautious Cochrane view.
- Schnipper et al. (2022): how to implement reconciliation across many hospitals.
- Penm et al. (2019): the international consensus definition.
Glossary
| Term | Turkish | Short definition |
|---|---|---|
| Medication reconciliation | İlaç uzlaştırma | Comparing an accurate medication list with orders at transitions. |
| Best possible medication history | En iyi olası ilaç öyküsü | Medication history verified from at least two sources. |
| Unintentional discrepancy | İstenmeyen uyumsuzluk | Unexplained difference between lists that is an error. |
| Transition of care | Bakım geçişi | Movement of a patient between settings or providers. |
| Medication review | İlaç gözden geçirme | Structured evaluation of the appropriateness of a regimen. |
| Polypharmacy | Çoklu ilaç kullanımı | Use of many medications, often five or more. |
| Potential adverse drug event | Potansiyel ilaç advers olayı | Error with capacity to cause harm. |
References
Breuker, C., Macioce, V., Mura, T., Castet-Nicolas, A., Audurier, Y., Boegner, C., Jalabert, A., Villiet, M., Avignon, A., & Sultan, A. (2021). Medication Errors at Hospital Admission and Discharge: Risk Factors and Impact of Medication Reconciliation Process to Improve Healthcare. Journal of Patient Safety, 17(7), E645-E652. https://doi.org/10.1097/PTS.0000000000000420
Bülow, C., Clausen, S. S., Lundh, A., & Christensen, M. (2023). Medication review in hospitalised patients to reduce morbidity and mortality. Cochrane Database of Systematic Reviews, CD008986. https://doi.org/10.1002/14651858.CD008986.pub4
Cengiz, K. N., Midi, I., & Sancar, M. (2025). The effect of clinical pharmacist-led pharmaceutical care services on medication adherence, clinical outcomes and quality of life in patients with stroke: a randomised controlled trial. International Journal of Clinical Pharmacy, 47(1), 99-106. https://doi.org/10.1007/s11096-024-01811-0
Ceschi, A., Noseda, R., Pironi, M., Lazzeri, N., Eberhardt-Gianella, O., Imelli, S., Ghidossi, S., Bruni, S., Pagnamenta, A., & Ferrari, P. (2021). Effect of Medication Reconciliation at Hospital Admission on 30-Day Returns to Hospital A Randomized Clinical Trial. JAMA Network Open, 4(9), e2124672. https://doi.org/10.1001/jamanetworkopen.2021.24672
Climente-Martí, M., García-Mañón, E. R., Artero-Mora, A., & Jiménez-Torres, N. V. (2010). Potential Risk of Medication Discrepancies and Reconciliation Errors at Admission and Discharge from an Inpatient Medical Service. Annals of Pharmacotherapy, 44(11), 1747-1754. https://doi.org/10.1345/aph.1P184
Coleman, E. A., Smith, J. D., Raha, D., & Min, S. J. (2005). Posthospital medication discrepancies – Prevalence and contributing factors. Archives of Internal Medicine, 165(16), 1842-1847. https://doi.org/10.1001/archinte.165.16.1842
Cornish, P. L., Knowles, S. R., Marchesano, R., Tam, V., Shadowitz, S., Juurlink, D. N., & Etchells, E. E. (2005). Unintended medication discrepancies at the time of hospital admission. Archives of Internal Medicine, 165(4), 424-429. https://doi.org/10.1001/archinte.165.4.424
Cornu, P., Steurbaut, S., Leysen, T., De Baere, E., Ligneel, C., Mets, T., & Dupont, A. G. (2012). Effect of Medication Reconciliation at Hospital Admission on Medication Discrepancies During Hospitalization and at Discharge for Geriatric Patients. Annals of Pharmacotherapy, 46(4), 484-494. https://doi.org/10.1345/aph.1Q594
Gleason, K. M., McDaniel, M. R., Feinglass, J., Baker, D. W., Lindquist, L., Liss, D., & Noskin, G. A. (2010). Results of the Medications At Transitions and Clinical Handoffs (MATCH) Study: An Analysis of Medication Reconciliation Errors and Risk Factors at Hospital Admission. Journal of General Internal Medicine, 25(5), 441-447. https://doi.org/10.1007/s11606-010-1256-6
Greenwald, J. L., Halasyamani, L., Greene, J., LaCivita, C., Stucky, E., Benjamin, B., Reid, W., Griffin, F. A., Vaida, A. J., & Williams, M. V. (2010). Making Inpatient Medication Reconciliation Patient Centered, Clinically Relevant and Implementable: A Consensus Statement on Key Principles and Necessary First Steps. Journal of Hospital Medicine, 5(8), 477-485. https://doi.org/10.1002/jhm.849
Joint Commission. (2025). Effectively managing medications (National Performance Goal #14) [Fact sheet]. https://digitalassets.jointcommission.org/api/public/content/d0c3745c2d7e494ca5199bd3af2a13bc
Kripalani, S., Jackson, A. T., Schnipper, J. L., & Coleman, E. A. (2007). Promoting effective transitions of care at hospital discharge: A review of key issues for hospitalists. Journal of Hospital Medicine, 2(5), 314-323. https://doi.org/10.1002/jhm.228
Kwan, J. L., Lo, L. S., Sampson, M., & Shojania, K. G. (2013). Medication Reconciliation During Transitions of Care as a Patient Safety Strategy A Systematic Review. Annals of Internal Medicine, 158(5), 397. https://doi.org/10.7326/0003-4819-158-5-201303051-00006
Lehnbom, E. C., Stewart, M. J., Manias, E., & Westbrook, J. I. (2014). Impact of Medication Reconciliation and Review on Clinical Outcomes. Annals of Pharmacotherapy, 48(10), 1298-1312. https://doi.org/10.1177/1060028014543485
Mekonnen, A. B., McLachlan, A. J., & Brien, J. A. E. (2016). Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open, 6(2), e010003. https://doi.org/10.1136/bmjopen-2015-010003
Mekonnen, A. B., McLachlan, A. J., & Brien, J. A. E. (2016). Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. Journal of Clinical Pharmacy and Therapeutics, 41(2), 128-144. https://doi.org/10.1111/jcpt.12364
Mueller, S. K., Sponsler, K. C., Kripalani, S., & Schnipper, J. L. (2012). Hospital-Based Medication Reconciliation Practices A Systematic Review. Archives of Internal Medicine, 172(14), 1057-1069. https://doi.org/10.1001/archinternmed.2012.2246
Penm, J., Vaillancourt, R., & Pouliot, A. (2019). Defining and identifying concepts of medication reconciliation: An international pharmacy perspective. Research in Social & Administrative Pharmacy, 15(6), 632-640. https://doi.org/10.1016/j.sapharm.2018.07.020
Phatak, A., Prusi, R., Ward, B., Hansen, L. O., Williams, M. V., Vetter, E., Chapman, N., & Postelnick, M. (2016). Impact of pharmacist involvement in the transitional care of high-risk patients through medication reconciliation, medication education, and postdischarge call-backs (IPITCH Study). Journal of Hospital Medicine, 11(1), 39-44. https://doi.org/10.1002/jhm.2493
Pippins, J. R., Gandhi, T. K., Hamann, C., Ndumele, C. D., Labonville, S. A., Diedrichsen, E. K., Carty, M. G., Karson, A. S., Bhan, I., Coley, C. M., Liang, C. L., Turchin, A., McCarthy, P. C., & Schnipper, J. L. (2008). Classifying and predicting errors of inpatient medication reconciliation. Journal of General Internal Medicine, 23(9), 1414-1422. https://doi.org/10.1007/s11606-008-0687-9
Pronovost, P., Weast, B., Schwarz, M., Wyskiel, R. M., Prow, D., Milanovich, S. N., Berenholtz, S., Dorman, T., & Lipsett, P. (2003). Medication reconciliation: A practical tool to reduce the risk of medication errors. Journal of Critical Care, 18(4), 201-205. https://doi.org/10.1016/j.jcrc.2003.10.001
Redmond, P., Grimes, T. C., McDonnell, R., Boland, F., Hughes, C., & Fahey, T. (2018). Impact of medication reconciliation for improving transitions of care. Cochrane Database of Systematic Reviews, CD010791. https://doi.org/10.1002/14651858.CD010791.pub2
Schnipper, J. L., Hamann, C., Ndumele, C. D., Liang, C. L., Carty, M. G., Karson, A. S., Bhan, I., Coley, C. M., Poon, E., Turchin, A., Labonville, S. A., Diedrichsen, E. K., Lipsitz, S., Broverman, C. A., McCarthy, P., & Gandhi, T. K. (2009). Effect of an Electronic Medication Reconciliation Application and Process Redesign on Potential Adverse Drug Events A Cluster-Randomized Trial. Archives of Internal Medicine, 169(8), 771-780. https://doi.org/10.1001/archinternmed.2009.51
Schnipper, J. L., Nieva, H. R., Mallouk, M., Mixon, A., Rennke, S., Chu, E., Mueller, S., Smith, G. R. J., Williams, M. V., Wetterneck, T. B., Stein, J., Dalal, A., Labonville, S., Sridharan, A., Stolldorf, D. P., Orav, E. J., Levin, B., Gresham, M., Yoon, C., . . ., & Kripalani, S. (2022). Effects of a refined evidence-based toolkit and mentored implementation on medication reconciliation at 18 hospitals: results of the MARQUIS2 study. BMJ Quality & Safety, 31(4), 278-286. https://doi.org/10.1136/bmjqs-2020-012709
Selcuk, A., Sancar, M., Okuyan, B., Demirtunc, R., & Izzettin, F. V. (2015). The potential role of clinical pharmacists in elderly patients during hospital admission. Pharmazie, 70(8), 559-562. https://doi.org/10.1691/ph.2015.5510
Studer, H., Imfeld-Isenegger, T. L., Beeler, P. E., Ceppi, M. G., Rosen, C., Bodmer, M., Boeni, F., Hersberger, K. E., & Lampert, M. L. (2023). The impact of pharmacist-led medication reconciliation and interprofessional ward rounds on drug-related problems at hospital discharge. International Journal of Clinical Pharmacy, 45(1), 117-125. https://doi.org/10.1007/s11096-022-01496-3
Wong, J. D., Bajcar, J. M., Wong, G. G., Alibhai, S. M. H., Huh, J. H., Cesta, A., Pond, G. R., & Fernandes, O. A. (2008). Medication reconciliation at hospital discharge: Evaluating discrepancies. Annals of Pharmacotherapy, 42(10), 1373-1379. https://doi.org/10.1345/aph.1L190
Source verification note
Author names, year, journal and DOI details of the 26 corpus-based citations were generated by code directly from the Web of Science records and checked one to one against the in-text citations; claims were checked at the level of record abstracts, and full texts were not read. The Joint Commission fact sheet was read in full on 16 November 2026. No source outside the corpus and the fact sheet is cited.
AI use statement
Anthropic’s Claude model was used to design and run the Web of Science search, tag and pre-screen records, extract evidence from abstracts, draft the English text and produce the figures. Final decisions, the scientific accuracy of the text and final responsibility rest with the author.
Data and supplementary material
The full list of the 956 core records and the 2,005 eligible records for this part (author, year, title, journal, DOI, component flags, “patient safety” layer flag and pre-screening suggestion), the screening log of the 4,936-record series corpus and the citation verification report are provided in the series companion workbook (NPG14_Series_Supplementary.xlsx), available from the author on request. The record list is deliberately kept out of the chapter text.
Series: Effectively Managing Medications (Joint Commission NPG #14)
- Series guide: Effectively Managing Medications (NPG #14)
- Part 1. Pharmacist Order Review When the Pharmacy Is Closed
- Part 2. Automated Dispensing Cabinets and Overrides
- Part 3. Medication Selection, Procurement and Shortages
- Part 4. Perioperative and Procedural Medication Labeling
- Part 5. Medication Reconciliation (you are here)
- Part 6. Anticoagulant Safety
- Part 7. Antimicrobial Stewardship in Hospitals
Cite this page (APA 7)
Kurutkan, M. N. (2026, November 16). Medication Reconciliation: An Introduction (101). The Health Topics. https://healthtopic.org/topics/medication-reconciliation-an-introduction-101/
